SCHEMBL22096832

SCHEMBL22096832

COCCNc1ncc(F)cc1C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 1/20 0.38
LDHA P00338 1/20 0.38
CYP3A4 P08684 6/20 0.37
CYP1A2 P05177 6/20 0.37
CYP2C19 P33261 5/20 0.37
HSD17B10 Q99714 4/20 0.37
CLK4 Q9HAZ1 4/20 0.37
TSHR P16473 3/20 0.37
ALDH1A1 P00352 3/20 0.37
ALOX15 P16050 2/20 0.37
MAPK1 P28482 2/20 0.37
CYP2D6 P10635 1/20 0.37
LMNA P02545 4/20 0.37
HTT P42858 2/20 0.37
KCNH3 Q9ULD8 2/20 0.37
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FYN P06241 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
SYK P43405 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19780263 0.80 LDHA (0.40) LDHACYP3A4CYP1A2CYP2C19HSD17B10
SCHEMBL22096893 0.79 EGLN2 (0.41) LDHACYP3A4CYP1A2CYP2C19HSD17B10
SCHEMBL23492902 0.79 LDHA (0.39) ULK1LDHACYP3A4CYP1A2CYP2C19
SCHEMBL19880473 0.78 ALDH1A1 (0.39) LDHACYP3A4CYP1A2CYP2C19HSD17B10
SCHEMBL19769042 0.77 P2RX3 (0.38) LDHACYP3A4CYP1A2CYP2C19HSD17B10
SCHEMBL22096834 0.72 MAPK1 (0.38) ALDH1A1MAPK1HTTMEN1KMT2A
SCHEMBL24869533 0.70 ULK1 (0.43) ULK1LDHACYP3A4CYP1A2CYP2C19
SCHEMBL16505576 0.70 LMNA (0.39) LDHAALDH1A1MAPK1LMNAHTT
SCHEMBL22096906 0.69 P2RY1 (0.36) MAPK1HTTMEN1KMT2A
SCHEMBL25625107 0.68 ULK1 (0.53) ULK1LDHACYP3A4CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875839-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-12-29 US disclosed
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190053-A1 SOMATOSTATIN MODULATORS AND USES THEREOF SSTR5, SSTR2, SSTR4 ULK1 626/4885LDHA 3305/4885CYP3A4 4648/4885
US-10875839-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 ULK1 626/4885LDHA 3305/4885CYP3A4 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.